Literature DB >> 591003

Chemotaxis for polymorphonuclear leucocytes induced by soluble antigen- antibody complexes.

J Leung-Tack, J Maillard, G A Voisin.   

Abstract

Guinea-pig soluble immune complexes formed either by simply mixing antibody and antigen in excess or by redissolving a washed immune precipitate with antigen, after incubation with fresh serum, could induce a migration of polymorphonuclear leucocytes in vitro. This chemotactic effect of soluble complexes, although less than that of insoluble complexes, persisted despite experimental changes in the specificity, the dose and the class of antibodies. Soluble complexes of various molecular compositions induced chemotaxis but the most efficient complex was of Ab 1 Ag 1 formula. Unlike larger complexes, the Ab 1 Ag 1 complexes induced little or no complement fixation. Another source of chemotactic mediators was needed, apparently related to the esterases of the contact system of coagulation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 591003      PMCID: PMC1445546     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  NONPRECIPITATING ANTIBODY AND THE ARTHUS VASCULITIS.

Authors:  H LEVENSON; C G COCHRANE
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

2.  [Measurement of catalase activity].

Authors:  H U BERGMEYER
Journal:  Biochem Z       Date:  1955

3.  Release of intracellular constituents from rabbit polymorphonuclear leukocytes exposed to soluble and insoluble immune complexes.

Authors:  N S Taichman; W Pruzanski; N S Ranadive
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

4.  Studies on circulating immune complexes. 3. Factors governing the ability of circulating complexes to localize in blood vessels.

Authors:  C G Cochrane; D Hawkins
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

5.  Triple pathway for induction of chemotaxis in neutrophil leucocytes by guinea-pig immune complexes of different Ig classes.

Authors:  J L Tack; F Beucher; J Maillard; G A Voisin
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

6.  The response of polymorphonuclear leukocytes to immune complexes in vitro.

Authors:  D Hawkins; S Peeters
Journal:  Lab Invest       Date:  1971-06       Impact factor: 5.662

Review 7.  Behaviour of mouse mast cells during anaphylaxis in vitro.

Authors:  N M Vaz; A Prouvost-Danon
Journal:  Prog Allergy       Date:  1969

8.  The interaction of Hageman factor and immune complexes.

Authors:  C G Cochrane; K D Wuepper; B S Aiken; S D Revak; H L Spiegelberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  Generation of chemotactic factors in guinea pig serum via activation of the classical and alternate complement pathways.

Authors:  R A Clark; M M Frank; H R Kimball
Journal:  Clin Immunol Immunopathol       Date:  1973-04

10.  Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

Authors:  H O Sjögren; I Hellström; S C Bansal; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

View more
  4 in total

1.  Inhibition of PMN leukocytes chemotaxis by thalidomide.

Authors:  M Faure; J Thivolet; M Gaucherand
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

2.  Investigations on vitamin E and lipid peroxide status in rheumatic diseases.

Authors:  M Mezes; G Bartosiewicz
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

3.  The kinetics of leucocyte migration into rabbit knee joints elicited by preformed immune complexes with different in vitro characteristics.

Authors:  L M Bjursten; P Thomsen; S Ahlstedt; U Bagge
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

4.  Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions.

Authors:  H H Sedlacek
Journal:  Klin Wochenschr       Date:  1980-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.